|
We are offering four exciting web seminars this fall. They are all free-of-charge and you are welcome to join us at one or all of them... Presentations will describe various application areas, including asthma and allergy research, antibody selection and antibody characterization. You will also discover how you can maximize resources while maintaining high standards of information content and data quality using:
 |
• |
 |
Biacore™ X100 with integrated application guidance and software support. A system well-suited for busy laboratories, facilitating system access for multiple projects and enabling users to obtain kinetic data within hours.
|
 |
• |
 |
Biacore Flexchip - Well suited for protein kinetic profiling in early research by generating data for hundreds of protein interactions simultaneously.
|
Date Passed. This webinar took place on September 20th. | "The application of Biacore systems to the diagnostic allergy laboratory" Prof. Robert Hamilton, John Hopkins University, USA |
Professor Robert Hamilton will present work aimed at identifying indicators of risk for, and protection from, allergic reactions through accurate quantification of allergen-specific IgE. Biacore X100 easily provides comparison of affinity and kinetic rate constants of, for example, interaction of purified, biotinylated FceRI-alpha with IgE Fc and the interaction of a biotherapeutic product with IgE Fc. Webinar recording not currently available. As this webinar presented new data that is currently unpublished, we are not able to provide a recording at this time.
Date Passed. This webinar took place on September 27th. | "Biacore X100 as a valuable tool in monoclonal antibody development: Analysis of anti-serum" Robert Gunnarsson, Mercodia, Sweden |
Mercodia, Sweden is a vendor of ELISA kits within the areas of Cardiovascular Disease, Obesity and Diabetes. Robert Gunnarsson will present their work in selecting right binder partners with the aim of developing highly sensitive ELISA kits for the clinical market. He will explain why antibody binding kinetics is an important selection criterion in ELISA development and how Biacore X100 has quickly enabled Mercodia to determine kinetic properties of their specific binders in an early stage of monoclonal development.
Date Passed. This webinar took place on October 9th. | "Direct cell binding of mAb as a tool to confirm membrane displayed receptor active conformation recognition" Dr. Gaetano Barbato, Merck Sharp & Dohme Research Laboratories, Italy |
Dr. Gaetano Barbato is the head of the Biophysics unit at Merck Sharp & Dohme Research Laboratories and Institutio di Ricerche di Biologia Moleculare in Pomieza, Italy. He will present some of the pioneering work his lab has done in finding antibodies binding to poorly characterized membrane bound target proteins. He will also describe how Biacore Flexchip enables new types of analyses that answer critical questions related to the development of antibodies against membrane bound proteins. Webinar recording not available. In accordance with the wishes of Dr. Barbato's company we are not able to bring you a recording of this web seminar.
Date Passed. This webinar took place on October 25, 2007. | "Extracellular matrix SPR arrays" Prof. Sylvie Ricard-Blum, University Lyon 1, France |
Professor Sylvie Ricard-Blum is an expert in the extracellular matrix. She will present her work using Biacore Flexchip for screening and characterizing protein-protein and protein-glycosaminoglycan interactions that take place within the extracellular matrix. She is currently studying the interactions underlying the biological activities of the extracellular molecules involved in the control of angiogenesis (the growth of new blood vessels from preexisting ones). Her seminar will focus on the preparation of protein and glycosaminoglycan arrays and on the results obtained. A major perspective of her work is the characterization of the entire extracellular interaction network with those SPR arrays. Webinar recording not currently available. As this webinar presented new data that is currently unpublished, we are not able to provide a recording at this time.
|